Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.75
-0.37 (-1.32%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Dianthus Therapeutics Employees
Dianthus Therapeutics had 53 employees as of December 31, 2023. The number of employees increased by 21 or 65.63% compared to the previous year.
Employees
53
Change (1Y)
21
Growth (1Y)
65.63%
Revenue / Employee
$77,698
Profits / Employee
-$1,069,453
Market Cap
814.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Healthcare Services Group | 33,400 |
| Embecta | 2,200 |
| AbCellera Biologics | 586 |
| Sana Biotechnology | 328 |
| Prothena Corporation | 173 |
| Silence Therapeutics | 109 |
| Annexon | 71 |
| 89bio | 70 |
DNTH News
- 14 days ago - Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting - GlobeNewsWire
- 2 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results - GlobeNewsWire
- 3 months ago - Dianthus: Improved Autoimmune Disorder Targeting With Classical Pathway Inhibition - Seeking Alpha
- 4 months ago - Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN) - GlobeNewsWire
- 4 months ago - Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN) - GlobeNewsWire
- 5 months ago - Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results - GlobeNewsWire
- 6 months ago - Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference - GlobeNewsWire